Enter numbers shown in the image * Other articles in this section [11/15/2013 22:22] PANGROL with

June 17 Office of the Food and Drug Administration USA (Food and Drug Administration - FDA) reported autosomal that the use of the antibiotic Maxipime / Maxipime (cefepime, Bristol-Myers Squibb / Elan ) is not associated with a higher risk of death in its use compared to other similar drugs. This is evidenced by FDA conducted within the framework of the ongoing review of drug safety analysis. The department also said that the appointment of Maxipime remains within the previously approved indications.
The updated review autosomal of the safety of drugs FDA noted that its experts have examined data previously published meta-analysis, which suggests a connection between the high mortality of patients in the application of Maxipime compared with the use of other β-lactam antibiotics. The FDA also reviewed the additional autosomal information provided Bristol-Myers Squibb , which was not included in the meta-analysis.
And Bristol-Myers autosomal Squibb , and the FDA, which continues to review the safety of Maxipime, will continue to review new data to conduct separate studies of its relationship with mortality of patients. Results are expected in about a year, say in management.
Fields marked with an asterisk are required Your Name * Rules of commenting comment to be published after moderation edition of the publication. We reserve the right not to publish posts that are irrelevant to the material and the topic of discussion. Certainly not: - profanity. - Comments that defame the reputation of companies, organizations, autosomal products, insults resource users, authors or participants articles. - Incitement to ethnic, religious or other hatred, incitement to unlawful acts; - advertising - posting autosomal links to other resources without the consent of a site moderator. E-Mail * Position, Message * Subscribe to new posts Colleagues Filling the example field is required to post comments and is designed to protect Internet resources from spam (junk e-mail messages).
Enter numbers shown in the image * Other articles in this section [11/15/2013 22:22] PANGROL with exocrine autosomal insufficiency - a simple answer to a difficult question [15/11/2013 14:20] Altai honey for your health! autosomal [14/11/2013 13:08] To drink or not to drink: a sense of proportion is welcome [11/08/2013 autosomal 20:48] As a balm to the soul: treat colds rationally [08/11/2013 19:49] Anti-depressants and sedatives . Two different paths to spiritual harmony [2013-11-08 17:10] DRY DRY - your assistant in extreme situations [11/08/2013 17:06] What are the horns of a person? [11/08/2013 15:03] Natural pharmacy, or What you did not know about garlic [11/07/2013 17:56] cedar oil: in harmony with nature! [11/07/2013 12:33] Absorbent articles Seni - comfort and confidence at any age, Latest News and Articles [11/15/2013 23:18] autosomal Perelіk preparatіv on yakі DERZHAVNAYA Service of Ukraine s lіkarskih zasobіv seen rozporyadzhennya about zaboronu / dozvіl їh realіzatsії s 11.08.2013 p. on 14.11.2013 p. [11/15/2013 22:49] Specialized Focus Conference "Farmpromotsiya in Ukraine. New Rules - 2013. Current Practice "[11/15/2013 22:22] autosomal PANGROL with exocrine insufficiency - a simple answer to a difficult question [11/15/2013 20:13] Rozporyadzhennya od 14.11.2013 p. 24672-1.2/2.0/17-13 [2013-11-15 20:13] Rozporyadzhennya od 14.11.2013 p. 24620-1.3/2.1/17-13 [2013-11-15 20:13] Rozporyadzhennya od 14.11.2013 p. 24585-1.3/2.0/17-13 [2013-11-15 20:12] Rozporyadzhennya od 13.11.2013 p. 24535-1.3/2.0/17-13 [2013-11-15 20:12] Rozporyadzhennya od 13.11.2013 p. 24534-1.3/2.0/17-13 [2013-11-15 autosomal 20:12] Rozporyadzhennya od 08.11.2013 p. 24185-1.2/2.0/17-13 [2013-11-15 20:11] List od 11.08.2013 p. 24173-1.2/2.0/17-13 Drugs, medicines and drug prices and all news